The vascular targeting agent combretastatin A-4-phosphate induces neutrophil recruitment to endothelial cells in vitro.

Míreanna comhchosúla

• Vascular effects dominate solid tumor response to treatment with combretastatin A-4-phosphate.
  de réir: Lunt, S, et al.
  Foilsithe / Cruthaithe: (2011)
• Vascular effects dominate solid tumor response to treatment with combretastatin A-4-phosphate
  de réir: Jane Lunt, S, et al.
  Foilsithe / Cruthaithe: (2011)
• Effects of combretastatin A4 phosphate on endothelial cell morphology in vitro and relationship to tumour vascular targeting activity in vivo.
  de réir: Galbraith, S, et al.
  Foilsithe / Cruthaithe: (2001)
• Mechanisms associated with tumor vascular shut-down induced by combretastatin A-4 phosphate: intravital microscopy and measurement of vascular permeability.
  de réir: Tozer, G, et al.
  Foilsithe / Cruthaithe: (2001)
• The vascular response of tumor and normal tissues in the rat to the vascular targeting agent, combretastatin A-4-phosphate, at clinically relevant doses.
  de réir: Prise, V, et al.
  Foilsithe / Cruthaithe: (2002)